Andreas Pfützner
Researcher Next ID · RN-024360
Researcher · Medicine
TH Bingen University of Applied Sciences
Bingen am Rhein, Luxembourg
- Works count
- 350
- Citation count
- 8,966
- H-index
- 50
- i10-index
- 180
Research interests
Publications
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
Diabetes Obesity and Metabolism · 2009 · https://doi.org/10.1111/j.1463-1326.2009.01056.x
Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein
Journal of the American College of Cardiology · 2007 · 10.1016/j.jacc.2006.08.054
High-Sensitivity C-Reactive Protein as Cardiovascular Risk Marker in Patients with Diabetes Mellitus
Diabetes Technology & Therapeutics · 2006 · 10.1089/dia.2006.8.28
Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus
Circulation · 2005 · https://doi.org/10.1161/01.cir.0000165072.01672.21
Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control
Journal of the American College of Cardiology · 2005 · https://doi.org/10.1016/j.jacc.2005.03.041
Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes
Diabetes Care · 2004 · 10.2337/diacare.27.3.682
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
PubMed · 2003
Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
Diabetes Care · 1999 · 10.2337/diacare.22.5.784
Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment
Diabetes · 1997 · https://doi.org/10.2337/diab.46.2.265
Current projects
No projects listed.